Grantham, Mayo, Van Otterloo & Co (GMO)’s MasTec MTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-58,700
Closed -$5.47M 564
2024
Q1
$5.47M Buy
+58,700
New +$4.46M 0.02% 301
2018
Q1
Sell
-11,600
Closed -$568K 612
2017
Q4
$568K Sell
11,600
-5,400
-32% -$241K ﹤0.01% 447
2017
Q3
$789K Sell
17,000
-11,100
-40% -$483K ﹤0.01% 390
2017
Q2
$1.27M Buy
28,100
+6,700
+31% +$290K 0.01% 354
2017
Q1
$857K Buy
+21,400
New +$819K ﹤0.01% 375

Other funds holding MTZ

Grantham, Mayo, Van Otterloo & Co (GMO)'s MTZ Position: Q2 2024 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of MasTec (MTZ) in Q2 2024, closing a stake of 58,700 shares — an estimated $5.47M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in MTZ in Q1 2017 and held it in 5 quarters. The position peaked at $5.47M in Q1 2024. 428 funds tracked by Wall St. Rank hold MTZ as of Q2 2024.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining MasTec position as of Q2 2024 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 58,700 MasTec shares in Q2 2024, an estimated $5.47M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in MasTec in Q1 2017 and held it in 5 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s MasTec position peaked at $5.47M in Q1 2024.
  • 428 funds tracked by Wall St. Rank held MasTec as of Q2 2024.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2024, filed 13 Aug 2024.